OpenAlex
PricingAboutJobs
Log inGet started
Work

Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer

HTML

Year: 2012
Type: review
Source: Journal of Thoracic Oncology
DOI: 10.1097/jto.0b013e31825493eb
Author: Vassiliki Papadimitrakopoulou
Institution: The University of Texas MD Anderson Cancer Center
Language: English

Topic: PI3K/AKT/mTOR signaling in cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: PI3K/AKT/mTOR pathway, non-small cell lung cancer, pathway inhibitors, personalized treatment, drug resistance, PI3K mutations, AKT mutations, mTOR mutations, targeted therapy, relapse, clinical development
SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute
OpenAlex ID: W2000263590
FWCI: 1.326
Cites: 176
Cited by: 232
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms